Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD16 antibody

This anti-CD16 antibody is a Mouse Monoclonal antibody detecting CD16 in FACS, IP and IHC. Suitable for Human.
Catalog No. ABIN203889

Quick Overview for CD16 antibody (ABIN203889)

Target

See all CD16 Antibodies
CD16

Reactivity

  • 142
  • 25
  • 20
  • 20
  • 20
  • 9
  • 8
  • 8
  • 8
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Human

Host

  • 124
  • 27
  • 15
  • 1
Mouse

Clonality

  • 140
  • 25
  • 1
Monoclonal

Conjugate

  • 64
  • 17
  • 13
  • 12
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD16 antibody is un-conjugated

Application

  • 138
  • 35
  • 28
  • 27
  • 27
  • 24
  • 23
  • 17
  • 6
  • 6
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunoprecipitation (IP), Immunohistochemistry (IHC)
  • Specificity

    Recognizes both allelic forms of CD16. Antibody blocks binding of complexed IgG to CD16.

    Purification

    Protein A purified

    Immunogen

    Human polymorphonuclear leukocytes.

    Isotype

    IgG1
  • Application Notes

    Approved: Flo, IHC, IP

    Usage: Antibody blocks binding of complexed IgG to CD16. Applications: Suitable for use in Flow Cytometry, Immunoprecipitation, Immunohistochemistry. The applications listed have been tested for the unmodified form of this product. Other forms have not been tested.

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    PBS,  pH 7.2, 5 % glycerol, 0.2 % BSA.

    Preservative

    Azide free
  • Target

    CD16

    Alternative Name

    CD16

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here:
Chat with us!